Liver-Specific Suppression of PLA2G6/iPLA₂β Improves Glucose and Lipid Metabolism in High-Fat Diet-Fed Mice

Shimizu, Kahori; Nishibata, Mana; Nagata, Katsuyuki; Hori, Sho; Michinaga, Shotaro; Kanehara, Miyuki; Hashimoto-Iwasaki, Miho; Sakurai, Fuminori; Shindou, Hideo; Tomita, Koji; Nishinaka, Toru; Mizuguchi, Hiroyuki

doi:https://doi.org/10.1096/fj.202504753RR

Liver-Specific Suppression of PLA2G6/iPLA₂β Improves Glucose and Lipid Metabolism in High-Fat Diet-Fed Mice

Shimizu, Kahori; Nishibata, Mana; Nagata, Katsuyuki et al.

FASEB Journal, 2026, 40(8), e71821

アクセス数:1,239件（2026-11-12 09:38 集計）

固定URL: https://hdl.handle.net/11094/104831

閲覧可能ファイル

ファイル	フォーマット	利用条件	サイズ	閲覧回数	利用開始日	説明	information
FASEBJ_40_8_e71821	pdf	なし	4.82 MB	92	2026.05.25

Creative Commons : 表示

論文情報

ファイル出力 EndNote Basic出力 Mendeley出力

タイトル	Liver-Specific Suppression of PLA2G6/iPLA₂β Improves Glucose and Lipid Metabolism in High-Fat Diet-Fed Mice
著者	NRID 1000050737749 1000050737749 ORCID 0000-0003-1574-5526 0000-0003-1574-5526 researchmap permalink kahorishimizu kahorishimizu 著者名 Shimizu, Kahori
	著者名 Nishibata, Mana
	著者名 Nagata, Katsuyuki
	著者名 Hori, Sho
	NRID 1000060624054 1000060624054 著者名 Michinaga, Shotaro
	著者名 Kanehara, Miyuki
	著者名 Hashimoto-Iwasaki, Miho
	NRID 1000070370939 1000070370939 researchmap permalink read0165081 read0165081 Scopus Author ID 7003748169 7003748169 著者名 Sakurai, Fuminori
	NRID 1000010401027 1000010401027 著者名 Shindou, Hideo
	著者名 Tomita, Koji
	NRID 1000090295642 1000090295642 著者名 Nishinaka, Toru
	NRID 1000050311387 1000050311387 ORCID 0000-0003-0594-8178 0000-0003-0594-8178 researchmap permalink read0165079 read0165079 Scopus Author ID 57195381326 57195381326 著者名 Mizuguchi, Hiroyuki
キーワード等	adenovirus vector
	diabetes mellitus
	metabolic disorders
	metabolic dysfunction-associated steatotic liver disease
	phospholipids
	PLA2G6
内容	Phospholipase A2 group VI (PLA2G6, also called iPLA2β) has been implicated in male fertility, neuronal disorders, and metabolic diseases. However, its therapeutic effects on metabolic disorders remain elusive. We investigated the effects of PLA2G6 suppression on glucose and lipid metabolism. Systemic inhibition of PLA2G6 in high-fat diet-fed mice reduced hepatic lipid droplet size without altering the levels of serum triglycerides and fasting blood glucose. Suppression of liver-specific 𝑃𝑙𝑎2𝑔6 utilizing the short-hairpin RNA knockdown technique using an adenovirus vector (Ad-shPLA2G6) altered phospholipid and fatty acid metabolites and suppressed hepatic lipid accumulation, serum triglyceride, fasting glucose, and insulin levels. Additionally, Ad-shPLA2G6 treatment downregulated lipid biosynthesis-related genes but upregulated peroxisomal fatty acid oxidation-related genes. These findings indicate that targeting hepatic 𝑃𝑙𝑎2𝑔6 modulates phospholipid and fatty acid metabolites and improves glucose and lipid metabolism, suggesting 𝑃𝑙𝑎2𝑔6 as a potential therapeutic target in metabolic disorders, including type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease.
抄録	Phospholipase A2 group VI (PLA2G6, also called iPLA2β) has been implicated in male fertility, neuronal disorders, and metabolic diseases. However, its therapeutic effects on metabolic disorders remain elusive. We investigated the effects of PLA2G6 suppression on glucose and lipid metabolism. Systemic inhibition of PLA2G6 in high-fat diet-fed mice reduced hepatic lipid droplet size without altering the levels of serum triglycerides and fasting blood glucose. Suppression of liver-specific 𝑃𝑙𝑎2𝑔6 utilizing the short-hairpin RNA knockdown technique using an adenovirus vector (Ad-shPLA2G6) altered phospholipid and fatty acid metabolites and suppressed hepatic lipid accumulation, serum triglyceride, fasting glucose, and insulin levels. Additionally, Ad-shPLA2G6 treatment downregulated lipid biosynthesis-related genes but upregulated peroxisomal fatty acid oxidation-related genes. These findings indicate that targeting hepatic 𝑃𝑙𝑎2𝑔6 modulates phospholipid and fatty acid metabolites and improves glucose and lipid metabolism, suggesting 𝑃𝑙𝑎2𝑔6 as a potential therapeutic target in metabolic disorders, including type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease.
出版者	John Wiley and Sons Inc
収録物名	FASEB Journal
巻(号)	40(8)
ページ	e71821
刊行年月	2026-04-20
言語	英語
ハンドルURL	https://hdl.handle.net/11094/104831
PISSN	08926638
eISSN	15306860
関連情報 (isIdenticalTo)	DOI (出版社版) https://doi.org/10.1096/fj.202504753RR
アクセス権	open access
権利情報	This article is licensed under a Creative Commons Attribution 4.0 International License.
出版タイプ	Version of Record
カテゴリ	学術雑誌論文 Journal Article

資源タイプ	学術雑誌論文
ローカル資源タイプ	学術雑誌論文
DCMI資源タイプ	text
DCTERMS.bibliographicCitation	FASEB Journal. 2026, 40(8), p. e71821
DC.title	Liver-Specific Suppression of PLA2G6/iPLA₂β Improves Glucose and Lipid Metabolism in High-Fat Diet-Fed Mice
DC.creator	Shimizu, Kahori
	Nishibata, Mana
	Nagata, Katsuyuki
	Hori, Sho
	Michinaga, Shotaro
	Kanehara, Miyuki
	Hashimoto-Iwasaki, Miho
	Sakurai, Fuminori
	Shindou, Hideo
	Tomita, Koji
	Nishinaka, Toru
	Mizuguchi, Hiroyuki
DC.publisher	John Wiley and Sons Inc
DC.language' scheme='DCTERMS.RFC1766	英語
DC.type' scheme='DCTERMS.DCMIType	text
DCTERMS.issued' scheme='DCTERMS.W3CDTF	2026-04-20
DC.identifier	https://doi.org/10.1096/fj.202504753RR
DC.subject	adenovirus vector
	diabetes mellitus
	metabolic disorders
	metabolic dysfunction-associated steatotic liver disease
	phospholipids
	PLA2G6
DC.description	Phospholipase A2 group VI (PLA2G6, also called iPLA2β) has been implicated in male fertility, neuronal disorders, and metabolic diseases. However, its therapeutic effects on metabolic disorders remain elusive. We investigated the effects of PLA2G6 suppression on glucose and lipid metabolism. Systemic inhibition of PLA2G6 in high-fat diet-fed mice reduced hepatic lipid droplet size without altering the levels of serum triglycerides and fasting blood glucose. Suppression of liver-specific 𝑃𝑙𝑎2𝑔6 utilizing the short-hairpin RNA knockdown technique using an adenovirus vector (Ad-shPLA2G6) altered phospholipid and fatty acid metabolites and suppressed hepatic lipid accumulation, serum triglyceride, fasting glucose, and insulin levels. Additionally, Ad-shPLA2G6 treatment downregulated lipid biosynthesis-related genes but upregulated peroxisomal fatty acid oxidation-related genes. These findings indicate that targeting hepatic 𝑃𝑙𝑎2𝑔6 modulates phospholipid and fatty acid metabolites and improves glucose and lipid metabolism, suggesting 𝑃𝑙𝑎2𝑔6 as a potential therapeutic target in metabolic disorders, including type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease.
DCTERMS.abstract	Phospholipase A2 group VI (PLA2G6, also called iPLA2β) has been implicated in male fertility, neuronal disorders, and metabolic diseases. However, its therapeutic effects on metabolic disorders remain elusive. We investigated the effects of PLA2G6 suppression on glucose and lipid metabolism. Systemic inhibition of PLA2G6 in high-fat diet-fed mice reduced hepatic lipid droplet size without altering the levels of serum triglycerides and fasting blood glucose. Suppression of liver-specific 𝑃𝑙𝑎2𝑔6 utilizing the short-hairpin RNA knockdown technique using an adenovirus vector (Ad-shPLA2G6) altered phospholipid and fatty acid metabolites and suppressed hepatic lipid accumulation, serum triglyceride, fasting glucose, and insulin levels. Additionally, Ad-shPLA2G6 treatment downregulated lipid biosynthesis-related genes but upregulated peroxisomal fatty acid oxidation-related genes. These findings indicate that targeting hepatic 𝑃𝑙𝑎2𝑔6 modulates phospholipid and fatty acid metabolites and improves glucose and lipid metabolism, suggesting 𝑃𝑙𝑎2𝑔6 as a potential therapeutic target in metabolic disorders, including type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease.
DC.rights	This article is licensed under a Creative Commons Attribution 4.0 International License.
DC.format	104831
citation_title	Liver-Specific Suppression of PLA2G6/iPLA₂β Improves Glucose and Lipid Metabolism in High-Fat Diet-Fed Mice
citation_author	Shimizu, Kahori
	Nishibata, Mana
	Nagata, Katsuyuki
	Hori, Sho
	Michinaga, Shotaro
	Kanehara, Miyuki
	Hashimoto-Iwasaki, Miho
	Sakurai, Fuminori
	Shindou, Hideo
	Tomita, Koji
	Nishinaka, Toru
	Mizuguchi, Hiroyuki
citation_publisher	John Wiley and Sons Inc
citation_language	英語
citation_date	2026-04-20
citation_journal_title	FASEB Journal
citation_volume	40
citation_issue	8
citation_firstpage	e71821
citation_doi	https://doi.org/10.1096/fj.202504753RR
citation_public_url	https://hdl.handle.net/11094/104831

Liver-Specific Suppression of PLA2G6/iPLA₂β Improves Glucose and Lipid Metabolism in High-Fat Diet-Fed Mice

閲覧可能ファイル

論文情報

論文詳細を表示